Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azathioprine adjunct to oral mini-pulse for active non-segmental vitiligo
PACTR202611480779877Phase 4Completed
- Sponsor
- Cairo University
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of azathioprine in Vitiligo (2 arms), sponsored by Cairo University. Primary endpoints: Disease arrest, Repigmentation and 1 more. Started May 2024; status: completed.
02
Drugs
azathioprine
03
Conditions
Vitiligo
Beyond the preview
Go deeper on PACTR202611480779877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202611480779877.